2020
Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides
ATZMONY L, MOYAL L, FEINMESSER M, GOROVITZ B, HIRSHBERG A, AMITAY-LAISH I, PRAG-NAVEH H, BARZILAI A, HODAK E. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides. Acta Dermato Venereologica 2020, 100: 5828. PMID: 32556361, PMCID: PMC9207631, DOI: 10.2340/00015555-3578.Peer-Reviewed Original ResearchConceptsFolliculotropic mycosis fungoidesMycosis fungoidesKi-67Inflammatory cellsCD20+ B cellsTumor-associated inflammatory cellsTumor-infiltrating inflammatory cellsVariant of mycosis fungoidesEarly-stage MFTumour cell immunoreactivityCD68+ macrophagesMiR-155 expressionTumor-stage MFStage-dependent increaseStatistically significant differenceIndolent stageMiR-155Clinicopathological stageCell immunoreactivityB cellsInflammatory dermatosesImmunohistochemical analysisProliferating lymphocytesFungoidesSignificant difference
2016
New insights into folliculotropic mycosis fungoides (FMF): A single-center experience
Hodak E, Amitay-Laish I, Atzmony L, Prag-Naveh H, Yanichkin N, Barzilai A, Kershenovich R, Feinmesser M. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience. Journal Of The American Academy Of Dermatology 2016, 75: 347-355. PMID: 27245278, DOI: 10.1016/j.jaad.2016.03.009.Peer-Reviewed Original ResearchConceptsFolliculotropic mycosis fungoidesMycosis fungoidesPattern of clinicopathological featuresAdvanced stageLong-term follow-upLack of long-term follow-upTertiary medical centerEarly-stage lesionsEarly-stage groupPresence of eosinophilsAggressive courseTumor stageClinicopathological presentationHistopathological discriminationPerifollicular infiltratePrognostic implicationsClinicopathological featuresInfiltration densityAcneiform lesionsClinical manifestationsIndurated plaquesFollow-upMultivariate analysisTumorMedical Center
2015
Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single‐centre experience
Atzmony L, Amitay-Laish I, Gurion R, Shahal-Zimra Y, Hodak E. Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single‐centre experience. Journal Of The European Academy Of Dermatology And Venereology 2015, 29: 2382-2389. PMID: 26299651, DOI: 10.1111/jdv.13243.Peer-Reviewed Original ResearchConceptsExtracorporeal photopheresisErythrodermic mycosis fungoidesSezary syndromeLeukaemic involvementMycosis fungoidesErythrodermic MFTreated with extracorporeal photopheresisBlood responseNarrow-band ultraviolet BSkin responsePatch-stage MFClinical response rateElectron beam radiotherapyTopical nitrogen mustardTertiary medical centreMultimodal approachBeam radiotherapyMultimodality regimenClinical responseAdjunctive therapyInterferon-aSurvival advantageMedical filesPhotopheresisPatients